Studies on radiosensitivity from an epidemiological point of view - overview of methods and results (Q34783514)

4 August 2017

1 reference

title

Studies on radiosensitivity from an epidemiological point of view - overview of methods and results (English)

1 reference

4 August 2017

1 reference

2

Jenny Chang-Claude

0 references

Dorothee Twardella

series ordinal

1

object named as

Dorothee Twardella

0 references

author name string

Dorothee Twardella

series ordinal

1

1 reference

4 August 2017

1 March 2002

1 reference

Radiotherapy and Oncology

4 August 2017

1 reference

4 August 2017

62

1 reference

4 August 2017

3

1 reference

4 August 2017

249-260

1 reference

Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Relationship between early and late normal-tissue injury after postmastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Patient-to-patient variability in the expression of radiation-induced normal tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Early and Late Normal-tissue Injury after Postmastectomy Radiotherapy Alone or Combined with Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Dose and volume effects on fibrosis after breast conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Normal tissue radiosensitivity--how important is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Altered apoptotic profiles in irradiated patients with increased toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Radiosensitivity in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Cancer risks in A-T heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Evidence for a Positive Correlation betweenin VitroRadiosensitivity of Normal Human Skin Fibroblasts and the Occurrence of Subcutaneous Fibrosis after Radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Radiation-induced micronucleus formation in human skin fibroblasts of patients showing severe and normal tissue damage after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Radiation sensitive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Radiation-induced comet-formation in human skin fibroblasts from radiotherapy patients with different normal tissue reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

No predictive value of the micronucleus assay for patients with severe acute reaction of normal tissue after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Normal tissue radiosensitivity in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Four radiation hypersensitivity cases and their implications for clinical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Evidence for individual differences in the radiosensitivity of human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Prognostic factors for acute and late skin reactions in radiotherapy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900491-1

7 January 2021

10.1016/S0167-8140(01)00491-1

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12175555